Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1988; Volume 33,Issue 4
  • You have access
    A novel high affinity class of Ca2+ channel blockers.
    J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
    Molecular Pharmacology April 1988, 33 (4) 363-369;
  • You have access
    Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
    K Thermos and T Reisine
    Molecular Pharmacology April 1988, 33 (4) 370-377;
  • You have access
    Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
    M E Goldsmith and K H Cowan
    Molecular Pharmacology April 1988, 33 (4) 378-383;
  • You have access
    Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
    G Yu, S Grant and R I Glazer
    Molecular Pharmacology April 1988, 33 (4) 384-388;
  • You have access
    Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
    R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
    Molecular Pharmacology April 1988, 33 (4) 389-395;
  • You have access
    Role of epoxide in neocarzinostatin chromophore stability and action.
    S H Lee and I H Goldberg
    Molecular Pharmacology April 1988, 33 (4) 396-401;
  • You have access
    Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
    Molecular Pharmacology April 1988, 33 (4) 402-413;
  • You have access
    Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    S K Fisher
    Molecular Pharmacology April 1988, 33 (4) 414-422;
  • You have access
    Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    L L Werling, P S Puttfarcken and B M Cox
    Molecular Pharmacology April 1988, 33 (4) 423-431;
  • You have access
    Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
    J Marie and C Roy
    Molecular Pharmacology April 1988, 33 (4) 432-440;
  • You have access
    The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
    W J Parsons, V Ramkumar and G L Stiles
    Molecular Pharmacology April 1988, 33 (4) 441-448;
  • You have access
    Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
    H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
    Molecular Pharmacology April 1988, 33 (4) 449-453;
  • You have access
    Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
    J M Zamora, H L Pearce and W T Beck
    Molecular Pharmacology April 1988, 33 (4) 454-462;
  • You have access
    Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria.
    F De Matteis
    Molecular Pharmacology April 1988, 33 (4) 463-469;
  • You have access
    Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
    I Debing, A P Ijzerman and G Vauquelin
    Molecular Pharmacology April 1988, 33 (4) 470-476;
  • You have access
    Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
    T P Binder and M W Duffel
    Molecular Pharmacology April 1988, 33 (4) 477-479;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 4
1 Apr 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics